Spontaneous intracerebral haemorrhages - Warfarin as a risk factor

Journal of Clinical Neuroscience

Volumn 10, Issue 5, 2003, Pages 550-552

  Lawrentschuk, Nathan ^a   Kariappa, Sonia ^a,b   Kaye, Andrew H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cerebral haemorrhage; International normalised ratio; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG SCREENING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VERTEBROBASILAR INSUFFICIENCY;

EID: 0141558894     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00160-7     Document Type: Article

References (14)

1. Hylek EM, Singer DE. Risk factors for intracranial haemorrhage in ann. Int Med 1994; 120: 897-902.
2. O'Brien DF, Basu S, O'Donnell JR, Roberts GA, Phillips J. The impact of aspirin therapy and anticoagulation on the prevalence of spontaneous subdural haematoma. Ir Med J 2000; 93: 244-246.
3. Franke CL, de Longe J, van Swieten JC, Op de Coul AAW, van Gijn J. Intracerabral hematomas during anticoagulant treatment. Stroke 1990; 21: 726-730.
4. Haemostasis and thrombosis task force: guidelines on oral anticoagulation: third edn. Br J Haematol 1998; 101: 374-387.
5. Anderson CS, Chakera TMH, Stewart-Zwynne EG, Jamrozik KD. Spectrum of primary intracerebral haemorrhage in Perth, Western Australia. 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 1994; 57: 936-940.
6. Chambers BR, Donnan GA, Bladin PF. An analysis of the first 700 consecutive admissions to the Austin Hospital Stroke Unit. Aust NZ J Med 1983; 13: 57-64.
7. Lefkovits J et al. Acute stroke outcome: effects of stroke type and risk factors. Aust NZ J Med 1992; 22: 30-35.
8. Schütz H, Bodeker R, Damian M, Krack P, Dorndorf W. Age-related spontaneous intracerebral haematoma in a German community. Stroke 1990; 21: 1412-1418.
9. Rådberg JA, Olsson JE, Rådberg CT. Prognostic parameters in spontaneous intracerebral haematomas with special reference to anticoagulant treatment. Stroke 1991; 22: 571-576.
10. Commonwealth (of Australia) Department of Health and Ageing. Health Access and Financing Division: Summary of Annual Reports. Commonwealth of Australia; www.health.gov.au; September, 2001.
11. Gullov AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation. The AFASAK 2 study. Arch Intern Med 1999; 159: 1322-1328.
12. Review article: warfarin or aspirin for non-rheumatic atrial fibrillation. Drug Therap Bull 1994; 32: 57-60.
13. van der Meer FJM, Rosendaal FR, Vandenbroucke P, Briët E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 1557-1562.
14. The Newcastle Anticoagulation Study Group: Effectiveness of anticoagulation among patients discharged from hospital on warfarin. Med J Aust 1998; 169: 243-246.